Ayala Pharmaceuticals Inc (ADXS)

[shub]

The strategy of pushing a number of constructs forward at once infers that we expect to be able to finance those trials in the near future.
There's a pretty good argument for going it alone as we get to keep all the profits...But the expense of a ph 3 trial is staggering.
We are getting some help and we have some cash, but costs are soon to be very large.